Ningbonxing Medical Electric Co (SHSE:601567) Research & Development: ¥608 Mil (TTM As of Mar. 2026)


SHSE:601567 Ningbo Sanxing Medical Electric Co Ltd SHSE:601567
69 GF Score
Price ¥14.94
GF Value ¥27.42
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Ningbonxing Medical Electric Co Research & Development?

Ningbonxing Medical Electric Co SHSE:601567 +1.08% 69 Research & Development is ¥608 Mil as of Mar. 2026. GuruFocus rates SHSE:601567 with a GF Score™ of 69/100 and a GF Value™ of ¥27.42 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Ningbonxing Medical Electric Co's Research & Development for the three months ended in Mar. 2026 was ¥118 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ¥608 Mil.

Ningbonxing Medical Electric Co  (SHSE:601567) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ningbonxing Medical Electric Co Research & Development Related Terms

Ningbonxing Medical Electric Co Research & Development Historical Data

* Premium members only.

The historical data trend for Ningbonxing Medical Electric Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ningbonxing Medical Electric Co Research & Development Chart

Ningbonxing Medical Electric Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 294.03 327.02 470.83 523.33 607.28

Ningbonxing Medical Electric Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117.04 139.61 165.33 185.30 118.18
SHSE:601567
69GF Score
Ningbo Sanxing Medical Electric Co Ltd SHSE:601567
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ningbonxing Medical Electric Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥608 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ¥608 Mil mean?
Ningbonxing Medical Electric Co (SHSE:601567) has a Research & Development of ¥608 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Ningbonxing Medical Electric Co and its competitors.
Is Ningbonxing Medical Electric Co's Research & Development too high?
Ningbonxing Medical Electric Co's current Research & Development is ¥608 Mil. Overall, Ningbonxing Medical Electric Co has a GF Score™ of 69/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ningbonxing Medical Electric Co's Research & Development compare to VRT and BE?
Ningbonxing Medical Electric Co's Research & Development of ¥608 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Industrial Products company?
A good Research & Development depends on the Industrial Products industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Ningbonxing Medical Electric Co and its competitors. Ningbonxing Medical Electric Co's current Research & Development is ¥608 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ningbonxing Medical Electric Co stock overvalued right now?
Based on GuruFocus' analysis, Ningbonxing Medical Electric Co (SHSE:601567) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥27.42, compared to a current price of ¥14.94 — trading 45.5% below its estimated fair value. The current Research & Development is ¥608 Mil. Ningbonxing Medical Electric Co's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Ningbonxing Medical Electric Co (SHSE:601567), the current Research & Development is ¥608 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ningbonxing Medical Electric Co (SHSE:601567) Overvalued in 2026?

Based on GuruFocus' analysis, Ningbonxing Medical Electric Co stock appears to be undervalued. The current stock price of ¥14.94 is trading 45.5% below its estimated GF Value™ of ¥27.42. GuruFocus considers Ningbonxing Medical Electric Co to be Significantly Undervalued.

Key valuation signals for SHSE:601567:

  • Research & Development: ¥608 Mil
  • GF Value™: ¥27.42 vs. price of ¥14.94 (45.5% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the SHSE:601567 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ningbonxing Medical Electric Co Business Description

Address Yinzhou Industrial Park, Jiangshan Town, Yinzhou District, Zhejiang Province, Ningbo, CHN, 315191
Ningbo Sanxing Medical Electric Co Ltd operates in the electricity measurement industry. The product portfolio of the group includes the Meter box, Smart substation, Switchgear, Power distribution automation devices, and others. The company also operates in the Medical Service segment, which is mainly engaged in the construction, operation, investment, and acquisition of hospitals, as well as the finance leasing of hospitals, among others. It generates the majority of its revenue from the Intelligent power distribution segment.
69GF Score

Get the complete analysis for SHSE:601567

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥14.94
Price
¥27.42
GF Value